# EDGAR Filing Document

**Accession Number:** 0001824185
**File Stem:** 0000000000-23-000485
**Filing Date:** 2023-1
**Character Count:** 2957
**Document Hash:** 2af426e2e5645e970176d9ab8c7ab794
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-23-000485.hdr.sgml**: 20230215

**ACCESSION NUMBER**: 0000000000-23-000485

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20230118

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** HH&L Acquisition Co.
- **CENTRAL INDEX KEY:** 0001824185
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MEDICAL LABORATORIES [8071]
- **IRS NUMBER:** 000000000
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** UPLOAD

**BUSINESS ADDRESS:**
- **STREET 1:** C/O SAPPHIRE QI LI, ONE EXCHANGE SQUARE
- **STREET 2:** 8 CONNAUGHT PLACE SUITE 3508
- **CITY:** CENTRAL
- **STATE:** K3
- **ZIP:** 00000
- **BUSINESS PHONE:** 852 6679 6578

**MAIL ADDRESS:**
- **STREET 1:** C/O SAPPHIRE QI LI, ONE EXCHANGE SQUARE
- **STREET 2:** 8 CONNAUGHT PLACE SUITE 3508
- **CITY:** CENTRAL
- **STATE:** K3
- **ZIP:** 00000

## Text-Extract

```

United States securities and exchange commission logo

                January 18, 2023

       Richard Qi Li
       Chief Executive Officer
       HH&L Acquisition Co.
       Suite 2001-2002, 20/F, York House
       The Landmark, 15 Queen   s Road Central
       Central, Hong Kong

                                                        Re: HH&L Acquisition
Co.
                                                            Preliminary Proxy
on Schedule 14A
                                                            Filed December 23,
2022
                                                            File No. 001-40006

       Dear Richard Qi Li:

              We have completed our review of your filing. We remind you that
the company and its
       management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding
       any review, comments, action or absence of action by the staff.

                Sincerely,

                Division of Corporation Finance

                Office of Industrial Applications and

                Services
       cc:                                              Joel L. Rubinstein,
Esq.

```

### Attached PDF Documents

**Attachment 1:** `filename1`

![img-0.jpeg](img-0.jpeg)

DIVISION OF
CORPORATION FINANCE

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

January 18, 2023

Richard Qi Li
Chief Executive Officer
HH&L Acquisition Co.
Suite 2001-2002, 20/F, York House
The Landmark, 15 Queen's Road Central
Central, Hong Kong

**Re: HH&L Acquisition Co.**
**Preliminary Proxy on Schedule 14A**
**Filed December 23, 2022**
**File No. 001-40006**

Dear Richard Qi Li:

We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

Sincerely,

Division of Corporation Finance
Office of Industrial Applications and
Services

cc: Joel L. Rubinstein, Esq.